Lazary, Judit <br/><br/>
Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists.  [electronic resource] 

 -  Trends in pharmacological sciences  May 2011 
 - 270-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1873-3735 
<br/><br/><label>Standard No.: </label>10.1016/j.tips.2011.02.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Obesity Agents--adverse effects<br/>Genetic Testing--methods<br/>Humans<br/>Obesity--drug therapy<br/>Piperidines--adverse effects<br/>Polymorphism, Genetic<br/>Precision Medicine--methods<br/>Pyrazoles--adverse effects<br/>Receptor, Cannabinoid, CB1--antagonists & inhibitors<br/>Rimonabant<br/>Substance-Related Disorders--drug therapy